234 related articles for article (PubMed ID: 26621260)
1. New treatment models for compulsive disorders.
Grant JE; Fineberg N; van Ameringen M; Cath D; Visser H; Carmi L; Pallanti S; Hollander E; van Balkom AJ
Eur Neuropsychopharmacol; 2016 May; 26(5):877-84. PubMed ID: 26621260
[TBL] [Abstract][Full Text] [Related]
2. Compulsivity in obsessive-compulsive disorder and addictions.
Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
[TBL] [Abstract][Full Text] [Related]
3. Compulsivity-A new trans-diagnostic research domain for the Roadmap for Mental Health Research in Europe (ROAMER) and Research Domain Criteria (RDoC) initiatives.
Fineberg NA; Menchon JM; Zohar J; Veltman DJ
Eur Neuropsychopharmacol; 2016 May; 26(5):797-9. PubMed ID: 27235689
[No Abstract] [Full Text] [Related]
4. The role of habit in compulsivity.
Gillan CM; Robbins TW; Sahakian BJ; van den Heuvel OA; van Wingen G
Eur Neuropsychopharmacol; 2016 May; 26(5):828-40. PubMed ID: 26774661
[TBL] [Abstract][Full Text] [Related]
5. The cost and impact of compulsivity: A research perspective.
Hollander E; Doernberg E; Shavitt R; Waterman RJ; Soreni N; Veltman DJ; Sahakian BJ; Fineberg NA
Eur Neuropsychopharmacol; 2016 May; 26(5):800-9. PubMed ID: 27235690
[TBL] [Abstract][Full Text] [Related]
6. Human compulsivity: A perspective from evolutionary medicine.
Stein DJ; Hermesh H; Eilam D; Segalas C; Zohar J; Menchon J; Nesse RM
Eur Neuropsychopharmacol; 2016 May; 26(5):869-76. PubMed ID: 26723168
[TBL] [Abstract][Full Text] [Related]
7. Brain circuitry of compulsivity.
van den Heuvel OA; van Wingen G; Soriano-Mas C; Alonso P; Chamberlain SR; Nakamae T; Denys D; Goudriaan AE; Veltman DJ
Eur Neuropsychopharmacol; 2016 May; 26(5):810-27. PubMed ID: 26711687
[TBL] [Abstract][Full Text] [Related]
8. Cognitive behavior therapy for obsessive-compulsive and related disorders.
Lewin AB; Wu MS; McGuire JF; Storch EA
Psychiatr Clin North Am; 2014 Sep; 37(3):415-45. PubMed ID: 25150570
[TBL] [Abstract][Full Text] [Related]
9. Behavioural addiction-A rising tide?
Chamberlain SR; Lochner C; Stein DJ; Goudriaan AE; van Holst RJ; Zohar J; Grant JE
Eur Neuropsychopharmacol; 2016 May; 26(5):841-55. PubMed ID: 26585600
[TBL] [Abstract][Full Text] [Related]
10. [A Case with Multiple Comorbidities of Obsessive-Compulsive and Related Disorders].
Arikawa A; Mito H; Motoyama M; Yamanishi K; Hayashida K; Maebayashi K; Matsunaga H
Seishin Shinkeigaku Zasshi; 2015; 117(11):893-901. PubMed ID: 26901889
[TBL] [Abstract][Full Text] [Related]
11. Current issues in the treatment of OC-spectrum conditions.
Wetterneck CT; Teng EJ; Stanley MA
Bull Menninger Clin; 2010; 74(2):141-66. PubMed ID: 20545493
[TBL] [Abstract][Full Text] [Related]
12. Treatment of obsessive-compulsive disorders (OCD) and obsessive-compulsive-related disorders (OCRD).
Krzyszkowiak W; Kuleta-Krzyszkowiak M; Krzanowska E
Psychiatr Pol; 2019 Aug; 53(4):825-843. PubMed ID: 31760412
[TBL] [Abstract][Full Text] [Related]
13. The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap.
Szechtman H; Harvey BH; Woody EZ; Hoffman KL
Pharmacol Rev; 2020 Jan; 72(1):80-151. PubMed ID: 31826934
[TBL] [Abstract][Full Text] [Related]
14. Obsessive-compulsive disorder in dermatology.
Mavrogiorgou P; Bader A; Stockfleth E; Juckel G
J Dtsch Dermatol Ges; 2015 Oct; 13(10):991-9. PubMed ID: 26408459
[TBL] [Abstract][Full Text] [Related]
15. Obsessive-compulsive and related disorders: a critical review of the new diagnostic class.
Abramowitz JS; Jacoby RJ
Annu Rev Clin Psychol; 2015; 11():165-86. PubMed ID: 25581239
[TBL] [Abstract][Full Text] [Related]
16. Psychocutaneous disease: Clinical perspectives.
Kuhn H; Mennella C; Magid M; Stamu-O'Brien C; Kroumpouzos G
J Am Acad Dermatol; 2017 May; 76(5):779-791. PubMed ID: 28411771
[TBL] [Abstract][Full Text] [Related]
17. Refining the diagnostic boundaries of compulsive hoarding: a critical review.
Pertusa A; Frost RO; Fullana MA; Samuels J; Steketee G; Tolin D; Saxena S; Leckman JF; Mataix-Cols D
Clin Psychol Rev; 2010 Jun; 30(4):371-86. PubMed ID: 20189280
[TBL] [Abstract][Full Text] [Related]
18. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania.
Chamberlain SR; Fineberg NA; Blackwell AD; Robbins TW; Sahakian BJ
Am J Psychiatry; 2006 Jul; 163(7):1282-4. PubMed ID: 16816237
[TBL] [Abstract][Full Text] [Related]
19. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders.
Monzani B; Rijsdijk F; Harris J; Mataix-Cols D
JAMA Psychiatry; 2014 Feb; 71(2):182-9. PubMed ID: 24369376
[TBL] [Abstract][Full Text] [Related]
20. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
